NCT05078528Recruiting
Low-cost Imaging Technology for Global Prevention of Cervical Cancer
Low-cost Mobile Colposcopy and Confocal Imaging for Global Prevention of Cervical Cancer
Source: ClinicalTrials.gov · Last updated 6 Feb 2025 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
Cervical cancer remains the first or second leading cause of cancer death among women in many low-and middle-income countries. Cervical cancer prevention programs in low-resource settings are hampered by a lack of personnel with appropriate clinical expertise, lack of pathology services, and lack of associated infrastructure. There is an urgent need for appropriate diagnostic tools to enable accurate screening and diagnosis in low-resource settings. The purpose of this study is to develop and validate a low-cost Multimodal Mobile Colposcope (MMC) for global cervical cancer prevention programs. This new device will combine the imaging capabilities of a mobile colposcope with the microscopic imaging capabilities of a fiber-optic confocal imaging probe.
- Status (registry)
- Recruiting
- Study type
- Interventional
- Enrollment
- 1060 (estimated)
- First submitted
- 4 Oct 2021
- Start date
- 20 Sept 2021
- Primary completion date
- 3 Aug 2025
- Lead sponsor
- Barretos Cancer Hospital
- Diseases
- Cervical cancer
- NCT number
- NCT05078528
What you commit to
- Study type: Interventional
- Planned participants: 1060
- From 20 Sept 2021 to the primary completion date, 3 Aug 2025
- 2 sites in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Women with known allergy to proflavine or acriflavine;
Age
- Women under 25 years of age;
Other
- Women who have undergone hysterectomy with removal of the cervix;
- Women who are pregnant or nursing at the time of enrollment;
- Incapacitated women or in vulnerable situations or who are not willing to give consent;
Who the study is looking for
- Women \>25 years of age;
- Women undergoing colposcopy due to abnormal cervical screening or follow-up for a history of dysplasia;
- Women of childbearing potential must have a negative urine or blood pregnancy test;
- Ability to understand and willingness to provide informed consent by signing specific Informed Consent Document.
Age in the registry: 25 years to - · Sex: Female · Does not accept healthy volunteers
Sites (2)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Barretos Cancer Hospital Coordinator of this site? Confirm its status | Barretos | Brazil | Recruiting |
| Irmandade Santa Casa de Misericordia de Porto Alegre Coordinator of this site? Confirm its status | Porto Alegre | Brazil | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.